Showing results (171-180 of 238) with videos related to

Sort By:
Pageof 24
Antimicrobial Agents and Chemotherapy|June 1, 1996
Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected womenS M Geletko, M Segarra, K H Mayer, et al.
International Journal of STD & AIDS|October 14, 2004
Dried blood spots are an acceptable and useful HIV surveillance tool in a remote developing world settingS S Solomon, S Pulimi, I I Rodriguez, et al.
Journal of Acquired Immune Deficiency Syndromes|January 11, 1991
Plasma adenosine deaminase2: a marker for human immunodeficiency virus infectionJ G Niedzwicki, N M Kouttab, K H Mayer, et al.
Circulatory Shock|September 1, 1994
Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsisC J Fisher, S M Opal, S F Lowry, et al.
AIDS Patient Care and Stds|July 17, 2008
Prevalence and incidence of sexually transmitted infections among South Indians at increased risk of HIV infectionN Kumarasamy, P Balakrishnan, K K Venkatesh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 1999
Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapyK H Mayer, S Boswell, R Goldstein, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 3, 1998
The social context of drinking, drug use, and unsafe sex in the Boston Young Men StudyG R Seage, K H Mayer, C Wold, et al.
International Journal of STD & AIDS|June 10, 2004
HIV-1 cord-blood seroprevalence of parturient women in Sihanoukville, CambodiaT Theng, P Sok, D Pugatch, et al.
AIDS Patient Care and Stds|August 24, 2011
Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of riskL E Taylor, A K DeLong, M A Maynard, et al.
Pageof 24